Shionogi Competitors and Similar CompaniesClear all

Shionogi's competitors and similar companies include Lilly and Astellas Pharma.

	Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.	Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.	Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
Founding Date	Founding Date 1878	Founding Date 1876	Founding Date 1923
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development mental health pharma	Tags Manufacturing & Industrial diabetes drug development oncology pharma	Tags Healthcare diabetes drug development oncology pharma
Locations	Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more	Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more	Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more
Employees	Employees 4,955	Employees 47,0009% increase	Employees 14,754
Valuation ($)	Valuation ($) 12.3 b	Valuation ($) 903.4 b	Valuation ($) 20.8 b
Financial
Revenue (est.)	Revenue (est.) ¥499.7b (FY, 2026)	Revenue (est.) $65.2b (FY, 2025)	Revenue (est.) ¥2.1t (FY, 2026)
Cost of goods	Cost of goods ¥55.5b (FY, 2026)	Cost of goods $11.1b (FY, 2025)	Cost of goods ¥213.8b (FY, 2026)
Gross profit	Gross profit ¥491.3b (FY, 2026)	Gross profit $54.1b (FY, 2025)	Gross profit ¥2t (FY, 2026)
Net income	Net income ¥205.9b (FY, 2026)	Net income $20.6b (FY, 2025)	Net income ¥291.6b (FY, 2026)